1. Home
  2. FOLD vs NMRK Comparison

FOLD vs NMRK Comparison

Compare FOLD & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.19

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Newmark Group Inc.

NMRK

Newmark Group Inc.

HOLD

Current Price

$17.49

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
NMRK
Founded
2002
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
FOLD
NMRK
Price
$14.19
$17.49
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$29.79
$19.40
AVG Volume (30 Days)
14.8M
1.3M
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
0.69%
EPS Growth
N/A
94.50
EPS
N/A
0.59
Revenue
$598,704,000.00
$3,160,782,000.00
Revenue This Year
$21.49
$21.82
Revenue Next Year
$18.25
$10.10
P/E Ratio
N/A
$29.70
Revenue Growth
21.28
20.95
52 Week Low
$5.51
$9.65
52 Week High
$14.36
$19.84

Technical Indicators

Market Signals
Indicator
FOLD
NMRK
Relative Strength Index (RSI) 91.10 53.56
Support Level $10.64 $16.98
Resistance Level $11.14 $17.87
Average True Range (ATR) 0.36 0.56
MACD 0.28 0.07
Stochastic Oscillator 96.46 68.00

Price Performance

Historical Comparison
FOLD
NMRK

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About NMRK Newmark Group Inc.

Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.

Share on Social Networks: